Team:LMU-Munich/Human Practice/Panel Discussion

• Team
  • Team
  • Financing
  • Collaborations
  • Attributions
• Project
  • Problem
  • BaKillus
    • sensing
    • adhesion
    • killing
    • suicide
  • Bacillus BioBrickBox 2.0
  • Modeling
  • B. subtilis
• Results
  • Results
  • Registry
  • Judging
• Notebook
  • Safety
  • Protocols
• Application
  • Diagnosis & Treatment
  • Pretest
  • Legal Issues
  • Financing & Intellectual Property
  • Expertise
• Human Practice
  • Meet ups
  • iGEM@school
  • SynBio Day
  • Panel Discussion
  • Rathenau Instituut

Panel Discussion

This year’s project BaKillus combines approaches gained by the synthetic biology with the medical issue fighting against MSRA. In July 2014 we organized the panel discussion “Does Germany need Synthetic Biology to improve the (personalized) medicine?” inviting citizens to join and learn more about this new appearing field of the modern biology. As our project BaKillus is related to the controversial issue applying engineered bacteria to cure patients in the distant future, our aim was to discuss discussing the acceptance of using the tools of synthetic biology in the modern medicine, in a population with a very critical opinion concerning the genetic engineering was our aim.

The event started with a short introduction about Synthetic Biology, given by Prof. Dr. Thorsten Mascher (LMU Munich, Synthetic Microbiology). He explained the characteristic features of synthetic biology, giving examples like the construction of a synthetic version of the third chromosome of Saccharomyces cerevisae.

In the main section, the moderator PD Bernd Giese (University of Bremen, Department of Technology Development and Design) and three invited scientists discussed the XXXX. At the end, the experts were open for questions from the audience.

We invited the following experts:

Prof. Dr. Ralf Wagner
University of Regensburg, Institute of Medical Microbiology and Hygiene

Dr. rer. nat. Martin Siemann-Herzberg
University Stuttgart, Germany, Institute of Biochemical Engineering

PD Dr. Alexander Bogner
Austrian Academy of Science, Institute for Technology Assessment

Dr. med. Frank Bartram - Unfortunately he had to decline his invitation.
First Chairman of the German Environmental Health Organization (Deutscher Berufsverband der Umweltmedizin)

To learn more about our experts (click here)

PD. Bernd Giese (Foto daneben)[http://www.tecdesign.uni-bremen.de/typo3/en/staff/academic-staff/dr-bernd-giese.html]
Bernd Giese is research associate at the Department of Technological Design and Development, University of Bremen with the focus on Synthetic Biology. In his time as post-doctoral fellow at the University of Greifswald he studied the molecular mechanisms of intracellular infection with Staphylococci, which are the target of BaKillus, and discovered mechanisms and factors involved in the infection of mammalian cells with these pathogens. He is current working in/at the following projects: Innovation and Technology Analysis of Synthetic Biology (SynBioTA) and Attentive Technologies – Guiding principles for an age-appropriate technology design (AttenTech)

Prof. Dr. Ralf Wagner [http://www.imhr.de/en/research/research-groups/prof-dr-ralf-wagner-2]
Ralf Wagner is university professor at the Institute of Medical Microbiology and Hygiene, University of Regensburg, where he is heading the Medical Microbiology and Gene Therapy Unit. He was amongst the first scientists to recognize the value of gene design and synthesis for different areas of biotechnology including vaccine development, thus consequently translating basic research tools into scalable technologies and a quickly emerging business in the field of Synthetic Biology. His current scientific focus lies on merging aspects of synthetic biology with state of the art vaccine development.

Dr. rer. nat. Martin Siemann-Herzberg (Foto daneben) [http://www.ibvt.uni-stuttgart.de/mitarbeiter/martin_siemann-herzberg.html]
Martin Siemann-Herzberg is deputy head of the institute of Biochemical Engineering, University Stuttgart with the speciality in Synthetic Biology and Systems Biology, emphasizing the application of science for technical purpose. MEHR?

PD Dr. Alexander Bogner (Foto daneben) [http://www.oeaw.ac.at/ita/ueber-uns/das-ita-team/alexander-bogner/person]
Alexander Bogner is a habilitated sociologist working in the Institute of Technology Assessment at the Austrian Academy of Science with the main emphasis on science, technic and environment, analysing Green Genetic Engineering and other upcoming technologies, like the Synthetic Biology, in the context of policy and the general public. His current project SYNENERGENE aims to pique public’s interest to the Synthetic Biology and fathom the possibilities of a responsible design of technology